Rhabdomyosarcoma Cancer from Diagnosis to Treatment
What is Rhabdomyosarcoma?
Rhabdomyosarcoma is a rare and aggressive cancer that develops from skeletal muscle cells - the muscles we use for movement.
It mainly affects children and adolescents, but it can also occur in adults.
Common sites include:
• Head and neck region
• Genitourinary tract
• Arms and legs
• Trunk or chest wall
There are three main types:
• Embryonal Rhabdomyosarcoma
• Alveolar Rhabdomyosarcoma
• Pleomorphic Rhabdomyosarcoma
Rhabdomyosarcoma is a rare and aggressive cancer that develops from skeletal muscle cells - the muscles we use for movement.
It mainly affects children and adolescents, but it can also occur in adults.
Common sites include:
• Head and neck region
• Genitourinary tract
• Arms and legs
• Trunk or chest wall
There are three main types:
• Embryonal Rhabdomyosarcoma
• Alveolar Rhabdomyosarcoma
• Pleomorphic Rhabdomyosarcoma
1. Initial Evaluation
Medical History & Physical Exam:
The doctor checks for a lump, swelling, or pain in a muscle area.
Medical History & Physical Exam:
Around the eye ➧ bulging or vision changes
Nose|throat ➧ nasal blockage or bleeding
Urinary area ➧ difficulty urinating or blood in urine
Early suspicion:
Any firm, painless, rapidly growing lump in a child or young adult should raise concern for RMS.
Medical History & Physical Exam:
The doctor checks for a lump, swelling, or pain in a muscle area.
Medical History & Physical Exam:
Around the eye ➧ bulging or vision changes
Nose|throat ➧ nasal blockage or bleeding
Urinary area ➧ difficulty urinating or blood in urine
Early suspicion:
Any firm, painless, rapidly growing lump in a child or young adult should raise concern for RMS.
2. Imaging and Scanning
Ultrasound
Often the first step to see if a lump is solid or cystic.
Helps guide needle biopsy.
Magnetic Resonance Imaging
The main imaging tool for soft tissue tumors.
Shows the tumor’s size, extent, and involvement of muscles, bones, and nerves.
Especially useful for tumors in limbs or head and neck.
CT Scan
Used when tumors are in the chest, abdomen, or pelvis.
Helps check for organ involvement or local spread.
Chest CT Scan
To check for lung metastases, which are common in RMS.
PET-CT
Detects active cancer cells and checks for distant metastasis in bones, lymph nodes, or other organs.
Bone Scan
Sometimes used to find cancer spread to bones.
Ultrasound
Often the first step to see if a lump is solid or cystic.
Helps guide needle biopsy.
Magnetic Resonance Imaging
The main imaging tool for soft tissue tumors.
Shows the tumor’s size, extent, and involvement of muscles, bones, and nerves.
Especially useful for tumors in limbs or head and neck.
CT Scan
Used when tumors are in the chest, abdomen, or pelvis.
Helps check for organ involvement or local spread.
Chest CT Scan
To check for lung metastases, which are common in RMS.
PET-CT
Detects active cancer cells and checks for distant metastasis in bones, lymph nodes, or other organs.
Bone Scan
Sometimes used to find cancer spread to bones.
3. Biopsy and Pathology
Core Needle Biopsy
The preferred diagnostic method.
A small tissue sample is taken using a needle under local anesthesia or imaging guidance.
Incisional Biopsy
Performed if the tumor is deep or the needle biopsy is inconclusive.
Histopathological Examination
Under a microscope, RMS cells look like immature muscle cells | rhabdomyoblasts.
Special stains such as desmin, myogenin, and MyoD1 confirm muscle origin.
Molecular Tests
Detect characteristic chromosomal translocations:
PAX3-FOXO1 or PAX7-FOXO1 fusion genes | in alveolar type.
Help identify subtype and guide targeted therapy.
Core Needle Biopsy
The preferred diagnostic method.
A small tissue sample is taken using a needle under local anesthesia or imaging guidance.
Incisional Biopsy
Performed if the tumor is deep or the needle biopsy is inconclusive.
Histopathological Examination
Under a microscope, RMS cells look like immature muscle cells | rhabdomyoblasts.
Special stains such as desmin, myogenin, and MyoD1 confirm muscle origin.
Molecular Tests
Detect characteristic chromosomal translocations:
PAX3-FOXO1 or PAX7-FOXO1 fusion genes | in alveolar type.
Help identify subtype and guide targeted therapy.
4. Staging and Risk Grouping
Rhabdomyosarcoma is staged based on:
• Tumor size and location
• Lymph node involvement
• Metastasis | spread
• Surgical resectability | whether it can be completely removed
I - Localized, favorable site, no spread
II - Localized, larger tumor, no lymph nodes
III - Localized but lymph nodes involved
IV - Distant metastasis
Patients are also grouped by risk:
Low-risk
localized, embryonal type
Intermediate-risk
alveolar type or limited spread
High-risk
metastatic at diagnosis
Rhabdomyosarcoma is staged based on:
• Tumor size and location
• Lymph node involvement
• Metastasis | spread
• Surgical resectability | whether it can be completely removed
I - Localized, favorable site, no spread
II - Localized, larger tumor, no lymph nodes
III - Localized but lymph nodes involved
IV - Distant metastasis
Patients are also grouped by risk:
Low-risk
localized, embryonal type
Intermediate-risk
alveolar type or limited spread
High-risk
metastatic at diagnosis
5. Treatment Options
➛ Surgery
The goal is complete removal of the tumor with wide margins of healthy tissue.
• Complete resection is preferred if safely possible.
• For tumors in difficult areas, only partial removal may be done initially.
• Additional treatments | chemo/radiation | help control what remains.
➛ Radiation Therapy
• Used when the tumor cannot be completely removed or to destroy microscopic residual cells.
• Helps preserve organ function.
• Advanced techniques like Intensity-Modulated Radiation Therapy are used to minimize damage to healthy tissue.
➛ Chemotherapy
Main systemic treatment for RMS - critical for all patients, even after surgery.
Kills cancer cells that may have spread to other parts of the body.
Common drug combinations:
Vincristine
Actinomycin D | Dactinomycin
Cyclophosphamide
Other combinations may include Ifosfamide and Etoposide.
Treatment is usually given over 6-12 months in cycles.
➛ Targeted Therapy & Immunotherapy
• Research is ongoing for drugs targeting PAX-FOXO1 fusion genes.
• IGF-1R inhibitors, mTOR inhibitors, and immune checkpoint inhibitors are being tested in clinical trials.
➛ Surgery
The goal is complete removal of the tumor with wide margins of healthy tissue.
• Complete resection is preferred if safely possible.
• For tumors in difficult areas, only partial removal may be done initially.
• Additional treatments | chemo/radiation | help control what remains.
➛ Radiation Therapy
• Used when the tumor cannot be completely removed or to destroy microscopic residual cells.
• Helps preserve organ function.
• Advanced techniques like Intensity-Modulated Radiation Therapy are used to minimize damage to healthy tissue.
➛ Chemotherapy
Main systemic treatment for RMS - critical for all patients, even after surgery.
Kills cancer cells that may have spread to other parts of the body.
Common drug combinations:
Vincristine
Actinomycin D | Dactinomycin
Cyclophosphamide
Other combinations may include Ifosfamide and Etoposide.
Treatment is usually given over 6-12 months in cycles.
➛ Targeted Therapy & Immunotherapy
• Research is ongoing for drugs targeting PAX-FOXO1 fusion genes.
• IGF-1R inhibitors, mTOR inhibitors, and immune checkpoint inhibitors are being tested in clinical trials.
6. Follow-Up Care
After Treatment:
Every 3 months for first 2 years
Every 6 months for next 3 years
Annually after 5 years
Includes:
Physical exam
MRI of original site
Chest CT for metastasis
Annual scans and checkups
Surveillance goals:
Detect recurrence early
Monitor growth and function
Manage side effects from chemotherapy or radiation
After Treatment:
Every 3 months for first 2 years
Every 6 months for next 3 years
Annually after 5 years
Includes:
Physical exam
MRI of original site
Chest CT for metastasis
Annual scans and checkups
Surveillance goals:
Detect recurrence early
Monitor growth and function
Manage side effects from chemotherapy or radiation
7. Supportive and Rehabilitation Care
Physical therapy:
Restores movement and strength after surgery.
Pain management:
Controls discomfort during treatment and recovery.
Nutritional support:
Helps maintain strength and healing.
Psychological counseling:
Supports emotional well-being.
Long-term care:
Monitors for secondary effects | like growth delay or fertility issues.
Palliative care:
For advanced cases, focuses on comfort and quality of life.
Physical therapy:
Restores movement and strength after surgery.
Pain management:
Controls discomfort during treatment and recovery.
Nutritional support:
Helps maintain strength and healing.
Psychological counseling:
Supports emotional well-being.
Long-term care:
Monitors for secondary effects | like growth delay or fertility issues.
Palliative care:
For advanced cases, focuses on comfort and quality of life.
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page